My FDA Social Media Hearing Presentations
As you no doubt know, FDA is hosting a public hearing on pharma's use of social media for Rx drug (and device) promotion next...
Pharma Marketing News Vol. 8, #10: Nov/Dec 2009
Welcome to the NOV/DEC 2009 issue of Pharma Marketing News.
Pharma’s Image Conundrum: Building Brand Loyalty and Consumer Confidence
In this guest article, Carla Stratfold, CEO at OnRequest Images, presents several key learnings and best practices that pharmas can follow when building brand and consumer loyalty.
A Few Things I Learned at FDA’s Social Media Hearing: What’s Next is What...
This article presents key takeaways from the FDA hearing, a synopsis of the presentations made by John Mack, Publisher, Pharma Marketing News, at the hearing, a review of Ignite Health's study regarding effectiveness of sponsored links, and the next steps in the process of issuing guidance.
Search Advertising Options for Pharma: What to Do While Waiting for Those Guidelines
In this article, Julie Batten, eMarketing Manager at Klick Pharma discusses pharma's options for search marketing in this period between the FDA public hearing and when the much anticipated draft and final guidance on the issue is published.
Consequences of Direct-to-Consumer Advertising: Links to Higher Prices and Less Competition
This article focuses on a new study that suggests drug price increases are engineered to cover the costs of Direct-to-Consumer Advertising (DTCA). Drug price trend data from AARP, AHRQ, and prescription drug consumer price index (CPI) are presented. Also, what's the link between DTCA and competition?
Pharma Marketing News Vol. 8, #10: Nov/Dec 2009
Welcome to the NOV/DEC 2009 issue of Pharma Marketing News.
Industry Groups will Eat Consumer Advocates’ Lunch at FDA Social Media Public Hearing
Speakers at FDA's upcoming November public hearing on social media have received the schedule of presentations, which you can find here.
Each speaker has 10...
Social Media Best Practices for Pharma Are Needed, Whatever Happens at FDA
Many pharma eMarketing pundits and FDA policy wonks out there are already predicting that nothing much will come out of the upcoming public hearing...
Expect FDA Social Media Draft Guidance Before End of 2010
Let me make a prediction: FDA's DDMAC will issue some version of draft guidance on the use of social medial for Rx drug/device promotion...
